CURRENT INVESTORS

5AM Ventures is a venture capital firm focused on building next-generation life science companies by backing their innovations at their earliest stages. Founded in 2002, 5AM Ventures has more than $400 million under management and is actively investing 5AM Ventures III, L.P., a $200 million fund. The firm has offices in Menlo Park, CA and Waltham, MA.

Formed by successful industry executives and experienced venture capitalists, the 5AM team takes a focused, hands-on approach to company building. In addition to leading investments and contributing as board members of its portfolio companies, 5AM is directly involved in company strategy, business development, and fundraising.

The 5AM portfolio, built on advanced life science technologies, is diversified among innovative platforms, spinouts from established biotechnology and pharmaceutical companies, and companies developing near-term products. For more information, visit www.5amventures.com.

 

Pangaea Ventures is a venture capital firm that invests in advanced materials, energy, biomedical, and environmental technology companies. With offices located in New Jersey and Vancouver, British Columbia, the company makes investments across the United States and Canada.

Managing two funds at this time, the Pangaea team provides effective support to its portfolio companies with its deep domain knowledge coupled with operational and transactional expertise. For more information, visit www.pangaeaventures.com.

 

Additional Funding

Semprus BioSciences has also secured funding from the Department of Defense, National Institutes of Health, and the National Science Foundation.